Blight, Andrew R.
Faculty of Health,
United Kingdom
2025 Rank: 25756
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Rehabilitation
Rank in SubField 1: 1934 out of 360881 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25756 | 26203 |
| Total Cites | 7930 | 9383 |
| H-index | 48 | 52 |
| Hm-index | 26 | 27 |
| Number of Single Authored Papers | 27 | 27 |
| Total Cites to Single Authored Papers | 1672 | 1743 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 2532 | 2720 |
| Number of Single+First+Last Authored Papers | 81 | 81 |
| Total Cites to Single+First+Last Authored Papers | 4521 | 5095 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5112 | 5599 |
| Ratio of Total Citations to Distinct Citing Papers | 1.55 | 1.68 |
| Self-Citation Percentage |
15.49%
|
|
Blight, Andrew R.
Acorda Therapeutics, Inc.,
United States
2024 Rank: 23764
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Rehabilitation
Rank in SubField 1: 1843 out of 341636 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23764 | 24164 |
| Total Cites | 7676 | 9089 |
| H-index | 48 | 52 |
| Hm-index | 26 | 27 |
| Number of Single Authored Papers | 26 | 26 |
| Total Cites to Single Authored Papers | 1654 | 1725 |
| Number of Single+First Authored Papers | 43 | 43 |
| Total Cites to Single+First Authored Papers | 2476 | 2663 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 4418 | 4991 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4907 | 5368 |
| Ratio of Total Citations to Distinct Citing Papers | 1.56 | 1.69 |
| Self-Citation Percentage |
15.55%
|
|
Blight, Andrew R.
Acorda Therapeutics, Inc.,
United States
2023 Rank: 22565
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Rehabilitation
Rank in SubField 1: 1781 out of 323273 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22565 | 22938 |
| Total Cites | 7331 | 8726 |
| H-index | 46 | 51 |
| Hm-index | 26 | 27 |
| Number of Single Authored Papers | 25 | 25 |
| Total Cites to Single Authored Papers | 1627 | 1698 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 2424 | 2610 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 4282 | 4854 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4652 | 5104 |
| Ratio of Total Citations to Distinct Citing Papers | 1.58 | 1.71 |
| Self-Citation Percentage |
15.99%
|
|
Blight, Andrew R.
Acorda Therapeutics, Inc.,
United States
2022 Rank: 21719
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Rehabilitation
Rank in SubField 1: 1755 out of 305851 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 21719 | 21043 |
| Total Cites | 6970 | 8315 |
| H-index | 44 | 50 |
| Hm-index | 25 | 26 |
| Number of Single Authored Papers | 26 | 26 |
| Total Cites to Single Authored Papers | 1610 | 1681 |
| Number of Single+First Authored Papers | 43 | 43 |
| Total Cites to Single+First Authored Papers | 2387 | 2570 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 4163 | 4730 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 4385 | 4813 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.73 |
| Self-Citation Percentage |
16.18%
|
|
Blight, Andrew R.
Acorda Therapeutics, Inc.,
United States
2021 Rank: 20026
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Rehabilitation
Rank in SubField 1: 1608 out of 278898 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20026 | 19826 |
| Total Cites | 6775 | 8096 |
| H-index | 44 | 50 |
| Hm-index | 25 | 26 |
| Number of Single Authored Papers | 26 | 26 |
| Total Cites to Single Authored Papers | 1583 | 1654 |
| Number of Single+First Authored Papers | 43 | 43 |
| Total Cites to Single+First Authored Papers | 2342 | 2523 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 4076 | 4641 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 4249 | 4665 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.74 |
| Self-Citation Percentage |
16.32%
|
|
Blight, Andrew R.
Acorda Therapeutics, Inc.,
United States
2020 Rank: 18719
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Rehabilitation
Rank in SubField 1: 1561 out of 227881 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 18719 | 18556 |
| Total Cites | 6363 | 7634 |
| H-index | 44 | 48 |
| Hm-index | 24 | 26 |
| Number of Single Authored Papers | 25 | 25 |
| Total Cites to Single Authored Papers | 1542 | 1613 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 2281 | 2458 |
| Number of Single+First+Last Authored Papers | 76 | 76 |
| Total Cites to Single+First+Last Authored Papers | 3889 | 4449 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 3967 | 4360 |
| Ratio of Total Citations to Distinct Citing Papers | 1.60 | 1.75 |
| Self-Citation Percentage |
16.65%
|
|
Related Profiles
Featured Profiles
Partner with Us
📢 Reach a targeted audience of science enthusiasts and professionals through our platform. Contact our marketing team:
business@topscinet.com cc: top2percentscientist@gmail.comGet a custom proposal tailored to your banner ad goals.
Partner with Us
📢 Partner with us and reach a targeted audience of science enthusiasts and professionals through our platform. Your company/institute’s banner could be here.